case_images: PMC9647296_01
case_images: Chest computed tomography (CT) findings of the patients before and after
  the treatment. In case 1, chest CT at presentation revealed diffuse
  ground-glass opacity (GGO), interlobular septal thickening, and
  reticular opacity in bilateral lower lobes (a). After steroid treatment,
  marked improvement was seen after 4 months (b). In case 2, ill-defined
  GGO was noted, mainly in the left lower lung field (c). Three months
  after discontinuation of dasatinib, GGO was decreased (d). In case 3,
  chest CT showed diffuse GGOs and peribronchial ill-defined nodules in
  the bilateral upper lobes, with a small amount of bilateral pleural
  effusion (e). With steroid treatment, follow-up chest CT after 1 month
  showed resolution of diffuse GGOs in both lungs (f).
case_images: 10.1177_17534666221135322-fig1.jpg
case_images: PMC9647296_03_10.1177_17534666221135322-fig1.jpg
case_images: fig1-17534666221135322
case_images: CRP, 2.84 mg/dl; procalcitonin, 0.13 ng/ml; aspartate transferase, 47 IU/L; and alanine transferase, 71 IU/L. Chest CT revealed diffuse GGO and peribronchial ill-defined nodules in the bilateral upper lobes, with a small amount of bilateral pleural effusion (shown in Figure 1(e)). She showed symptomatic improvement, and follow-up chest CT showed resolution of diffuse GGOs in both lungs (shown in Figure 1(f)).
case_images: Pathologic features of the video-assisted thoracoscopic lung biopsy. The
  alveolar walls are thickened by a uniform, cellular, inflammatory
  interstitial infiltrate including lymphocytes, plasma cells, and
  histiocytes without architectural distortion (hematoxylin and eosin
  stain, 1.4x). Inset: Peribronchiolar lymphohistiocytic aggregates and
  noncaseating granulomatous inflammation (hematoxylin and eosin stain,
  20x).
case_images: 10.1177_17534666221135322-fig2.jpg
case_images: PMC9647296_01_10.1177_17534666221135322-fig2.jpg
case_images: fig2-17534666221135322
case_images: Histologically, the alveolar walls were thickened by a uniform, cellular, and inflammatory interstitial infiltrate including lymphocytes, plasma cells, and histiocytes without architectural distortion (shown in Figure 2).
case_images: PMC9647296_02
case_images: Chest computed tomography (CT) findings of the patients before and after
  the treatment. In case 1, chest CT at presentation revealed diffuse
  ground-glass opacity (GGO), interlobular septal thickening, and
  reticular opacity in bilateral lower lobes (a). After steroid treatment,
  marked improvement was seen after 4 months (b). In case 2, ill-defined
  GGO was noted, mainly in the left lower lung field (c). Three months
  after discontinuation of dasatinib, GGO was decreased (d). In case 3,
  chest CT showed diffuse GGOs and peribronchial ill-defined nodules in
  the bilateral upper lobes, with a small amount of bilateral pleural
  effusion (e). With steroid treatment, follow-up chest CT after 1 month
  showed resolution of diffuse GGOs in both lungs (f).
case_images: 10.1177_17534666221135322-fig1.jpg
case_images: PMC9647296_03_10.1177_17534666221135322-fig1.jpg
case_images: fig1-17534666221135322
case_images: CRP, 2.84 mg/dl; procalcitonin, 0.13 ng/ml; aspartate transferase, 47 IU/L; and alanine transferase, 71 IU/L. Chest CT revealed diffuse GGO and peribronchial ill-defined nodules in the bilateral upper lobes, with a small amount of bilateral pleural effusion (shown in Figure 1(e)). She showed symptomatic improvement, and follow-up chest CT showed resolution of diffuse GGOs in both lungs (shown in Figure 1(f)).
case_images: PMC9647296_03
case_images: Chest computed tomography (CT) findings of the patients before and after
  the treatment. In case 1, chest CT at presentation revealed diffuse
  ground-glass opacity (GGO), interlobular septal thickening, and
  reticular opacity in bilateral lower lobes (a). After steroid treatment,
  marked improvement was seen after 4 months (b). In case 2, ill-defined
  GGO was noted, mainly in the left lower lung field (c). Three months
  after discontinuation of dasatinib, GGO was decreased (d). In case 3,
  chest CT showed diffuse GGOs and peribronchial ill-defined nodules in
  the bilateral upper lobes, with a small amount of bilateral pleural
  effusion (e). With steroid treatment, follow-up chest CT after 1 month
  showed resolution of diffuse GGOs in both lungs (f).
case_images: 10.1177_17534666221135322-fig1.jpg
case_images: PMC9647296_03_10.1177_17534666221135322-fig1.jpg
case_images: fig1-17534666221135322
case_images: CRP, 2.84 mg/dl; procalcitonin, 0.13 ng/ml; aspartate transferase, 47 IU/L; and alanine transferase, 71 IU/L. Chest CT revealed diffuse GGO and peribronchial ill-defined nodules in the bilateral upper lobes, with a small amount of bilateral pleural effusion (shown in Figure 1(e)). She showed symptomatic improvement, and follow-up chest CT showed resolution of diffuse GGOs in both lungs (shown in Figure 1(f)).